Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review

Christopher J McNally,1,2 Mark W Ruddock,1 Tara Moore,2 Declan J McKenna2 1Randox Laboratories Ltd, Crumlin, Co. Antrim BT29 4QY, Northern Ireland; 2Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, Northern IrelandCorrespondence: Declan J McKenna Tel +44 2870124356Email...

Full description

Bibliographic Details
Main Authors:	McNally CJ, Ruddock MW, Moore T, McKenna DJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-07-01
Series:	Cancer Management and Research
Subjects:	prostate cancer benign prostatic hyperplasia biomarkers differentiation trans-rectal ultrasound guided biopsy
Online Access:	https://www.dovepress.com/biomarkers-that-differentiate-benign-prostatic-hyperplasia-from-prosta-peer-reviewed-article-CMAR

Similar Items

Digital rectal grading of benign prostatic hyperplasia: Where does it stand today?
by: Bijit Lodh, et al.
Published: (2016-01-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

Cadmium Concentration and Metallothionein Expression in Prostate Cancer and Benign Prostatic Hyperplasia of Humans
by: Jane-Dar Lee, et al.
Published: (2009-07-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
by: Mohamed Shaker, et al.
Published: (2016-09-01)

Frequency of common complications during treatment of patients with benign prostate hyperplasia
by: Kričković Zoran, et al.
Published: (2020-01-01)

Outcome of Surgery for Benign Prostatic Hyperplasia-Is It Predictable?
by: Suhani, et al.
Published: (2013-12-01)

Accurate Cut-off Point for Free to Total Prostate- Specific Antigen Ratio Used to Improve Differentiation of Prostate Cancer from Benign Prostate Hyperplasia in Iranian Population
by: Khosro Rahbar, et al.
Published: (2010-05-01)

Comparison of telomerase activity in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic hyperplasia
by: Soleiman Mahjoub, et al.
Published: (2006-11-01)

Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators
by: Hanna Andrusewicz, et al.
Published: (2011-10-01)

An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
by: Aditya Srinivasan, et al.
Published: (2020-10-01)

INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: A. I. Neymark, et al.
Published: (2015-09-01)

Adipocytokine levels in benign prostate hyperplasia and prostate cancer patients
by: Gokhan Temeltas, et al.
Published: (2017-09-01)

A MICROBIAL CONTAMINATION OF PROSTATIC TISSUE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: Y. L. Naboka, et al.
Published: (2013-03-01)

The effect of transurethral prostate resection due to benign prostate hyperplasia on sexual functions
by: Sedat Tastemur, et al.
Published: (2021-09-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Outcomes of prostate artery embolisation for benign prostatic hyperplasia in 10 cases at Steve Biko Academic Hospital
by: Hatty G. Fischer, et al.
Published: (2019-02-01)

Pharmacological and nutritive support of patients with benign prostatic hyperplasia and chronic prostatitis
by: A. B. Bat'ko
Published: (2015-04-01)

Pharmacological and nutritive support of patients with benign prostatic hyperplasia and chronic prostatitis
by: A. B. Bat ,ko
Published: (2015-04-01)

Minimally invasive treatments for benign prostatic hyperplasia
by: Brian A VanderBrink, et al.
Published: (2006-01-01)

Giant prostatic hyperplasia and its causes
by: Marius Anglickis, et al.
Published: (2020-04-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Ivan Pezelj, et al.
Published: (2018-01-01)

One day hospitalization for trans-rectal ultrasound guided prostate biopsy: Experiences of a single institution
by: Ian-Seng Cheong, et al.
Published: (2017-12-01)

Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Centre in Udaipur, Rajasthan
by: Gulshan Kumar Mukhiya, et al.
Published: (2021-04-01)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
by: Ida Bagus O.W. Putra, et al.
Published: (2016-06-01)

Comparison of therapeutic effects of green laser enucleation of the prostate and transurethral prostate resection for treatment of benign prostatic hyperplasia
by: WEN Shuang, et al.
Published: (2020-09-01)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
by: Lee WC, et al.
Published: (2013-11-01)

The LEST technique: Treatment of prostatic obstruction preserving antegrade ejaculation in patients with benign prostatic hyperplasia
by: Rosario Leonardi
Published: (2019-03-01)

Treatment outcomes of benign prostate hyperplasia by thulium vapoenucleation of the prostate in aging men
by: Chun-Ming Hou, et al.
Published: (2016-12-01)

Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study
by: Wishyar Jamal Al-Bazzaz, et al.
Published: (2020-12-01)

Effects of isoflavones in patients with watchful waiting benign prostate hyperplasia.
Published: (2009)

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT
by: Alexei Pleșacov, et al.
Published: (2021-05-01)

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT
by: Alexei Pleșacov, et al.
Published: (2021-05-01)

OUTCOME COMPARISON OF TRANSURETHRAL RESECTION PROSTATE IN BENIGN PROSTATIC HYPERPLASIA PATIENT IN KARAWANG GENERAL REFERRAL HOSPITAL
by: Ramlan Halimi, et al.
Published: (2020-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019-01-01)